Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ge Shen

Showing results (51-60 of 111) with videos related to

Pageof 12
Sort By:
ACS Applied Materials & Interfaces|July 2, 2014
Growth and bending-sensitive photoluminescence of a flexible PbTiO₃/ZnO nanocompositeShan Jiang, Zhaohui Ren, Simin Yin, et al.
Journal of Medical Virology|July 1, 2020
Matrix metalloproteinase 3 as a valuable marker for patients with COVID-19Shengjie Shi, Min Su, Ge Shen, et al.
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|November 22, 2011
[Clinical study on viral hepatitis combined with aplastic anemia]Yao Lu, Yan-li Zhang, Ge Shen, et al.
Clinical and Experimental Medicine|May 22, 2019
Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapyRuyu Liu, Jiang Guo, Yao Lu, et al.
Frontiers in Oncology|September 2, 2022
Case report: The effective response to pembrolizumab in combination with bevacizumab in the treatment of a recurrent glioblastoma with multiple extracranial metastasesGang Yang, Yu Fang, Ming Zhou, et al.
Journal of Viral Hepatitis|March 31, 2022
Hepatitis B core-related antigen serum levels are associated with significant liver fibrosis in treatment-naive chronic HBV infection patientsRuyu Liu, Minghui Li, Yao Lu, et al.
Oncotarget|June 19, 2017
Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapyChao Liu, Shikai Wu, Xiangying Meng, et al.
Signal Transduction and Targeted Therapy|July 27, 2025
Genetic subtype-guided immunochemotherapy in relapsed and refractory diffuse large B cell lymphoma: a phase 2 investigator-initiated nonrandomized clinical trial (GUIDANCE-06)Yi-Ge Shen, Qing Shi, Wei Tang, et al.
Mediators of Inflammation|July 20, 2016
Effects of Chinese Propolis in Protecting Bovine Mammary Epithelial Cells against Mastitis Pathogens-Induced Cell DamageKai Wang, Xiao-Lu Jin, Xiao-Ge Shen, et al.
BMC Infectious Diseases|August 12, 2020
The reduction in CD8<sup>+</sup>PD-1<sup>+</sup> T cells in liver histological tissue is related to Pegylated IFN-α therapy outcomes in chronic hepatitis B patientsRuyu Liu, Yanhui Chen, Jiang Guo, et al.
Pageof 12

Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
ACS Applied Materials & Interfaces|July 2, 2014
Growth and bending-sensitive photoluminescence of a flexible PbTiO₃/ZnO nanocompositeShan Jiang, Zhaohui Ren, Simin Yin, et al.
Journal of Medical Virology|July 1, 2020
Matrix metalloproteinase 3 as a valuable marker for patients with COVID-19Shengjie Shi, Min Su, Ge Shen, et al.
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|November 22, 2011
[Clinical study on viral hepatitis combined with aplastic anemia]Yao Lu, Yan-li Zhang, Ge Shen, et al.
Clinical and Experimental Medicine|May 22, 2019
Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapyRuyu Liu, Jiang Guo, Yao Lu, et al.
Frontiers in Oncology|September 2, 2022
Case report: The effective response to pembrolizumab in combination with bevacizumab in the treatment of a recurrent glioblastoma with multiple extracranial metastasesGang Yang, Yu Fang, Ming Zhou, et al.
Journal of Viral Hepatitis|March 31, 2022
Hepatitis B core-related antigen serum levels are associated with significant liver fibrosis in treatment-naive chronic HBV infection patientsRuyu Liu, Minghui Li, Yao Lu, et al.
Oncotarget|June 19, 2017
Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapyChao Liu, Shikai Wu, Xiangying Meng, et al.
Signal Transduction and Targeted Therapy|July 27, 2025
Genetic subtype-guided immunochemotherapy in relapsed and refractory diffuse large B cell lymphoma: a phase 2 investigator-initiated nonrandomized clinical trial (GUIDANCE-06)Yi-Ge Shen, Qing Shi, Wei Tang, et al.
Mediators of Inflammation|July 20, 2016
Effects of Chinese Propolis in Protecting Bovine Mammary Epithelial Cells against Mastitis Pathogens-Induced Cell DamageKai Wang, Xiao-Lu Jin, Xiao-Ge Shen, et al.
BMC Infectious Diseases|August 12, 2020
The reduction in CD8<sup>+</sup>PD-1<sup>+</sup> T cells in liver histological tissue is related to Pegylated IFN-α therapy outcomes in chronic hepatitis B patientsRuyu Liu, Yanhui Chen, Jiang Guo, et al.
Pageof 12